NCT07361380 Non-Invasive Testing Device for Anaemia
| NCT ID | NCT07361380 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oxford |
| Condition | Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-10-28 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-10-28 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anaemia (iron deficiency) arises from a reduction in the number of healthy red blood cells or the level of haemoglobin (Hb) (a protein inside red blood cells) necessary to effectively transport oxygen throughout the body. Anaemia is common among pregnant women. The gold standard for anaemia diagnosis still relies on laboratory blood tests, which come with limitations in terms of point-of-care capability, accessibility and quality. The investigators have developed a portable and user-friendly device capable of detecting anaemia rapidly and non-invasively and facilitating appropriate treatment by distinguishing anaemia due to iron deficiency from other causes. The device, named The Vascular Imaging Tool for the Auricle (VITA), utilises high-resolution imaging technology to capture detailed images of blood cells and small blood vessels within the human body. The objectives of this study are to assess VITA's performance of (haemoglobin (Hb)) testing and its ability to identify iron deficiency anaemia against the clinical gold standard of laboratory blood tests.
Eligibility Criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Pregnant * Aged 16-50 years Exclusion Criteria: * Ear piercings that cannot be temporarily removed that would prevent the ability of the VITA device to take images of the ear blood vessels. * Ear piercings that would be visible on the ear blood vessel images
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07361380 clinical trial?
This trial is open to female participants only, aged 16 Years or older, up to 50 Years, studying Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07361380 currently recruiting?
Yes, NCT07361380 is actively recruiting participants. Contact the research team at paul.leeson@cardiov.ox.ac.uk for enrollment information.
Where is the NCT07361380 trial being conducted?
This trial is being conducted at Oxford, United Kingdom.
Who is sponsoring the NCT07361380 clinical trial?
NCT07361380 is sponsored by University of Oxford. The trial plans to enroll 300 participants.